SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Jul 3, 2023

2. SEC Identification Number

CS200251064

3. BIR Tax Identification No.

219075614

4. Exact name of issuer as specified in its charter

MEDILINES DISTRIBUTORS INCORPORATED

5. Province, country or other jurisdiction of incorporation

Metro Manila, Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

3rd Floor, Vistamall Hub, C.V. Starr Ave., Pamplona Dos, Las Pinas City Postal Code 1740

8. Issuer's telephone number, including area code

+6377471076/+6385192012

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	2,746,575,800

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC

PSE Disclosure Form 4-31 - Press Release References: SRC Rule 17 (SEC Form 17-C)
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Medilines Reports Outstanding Performance for 2022
Background/Description of the Disclosure
It’s another banner year for Medilines as the Company recorded twenty-four percent (24%) growth in revenues year-on-year with Php1.96 billion sales as of December 31, 2022; while its core net income grew by fifty-two percent (52%) year-on-year with Php215 Million. Amidst a persistent positive performance, Medilines maintains its record of sharing its growing income through yearly declaration of dividends. It has recently approved the declaration of cash dividends of 15% of the Company’s net income after tax for the year ended December 31, 2022....
Other Relevant Information
Please see attached Form 17-C for the full report